The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Safety and Efficacy of a Recombinant Hepatitis E Vaccine
Abstract
BACKGROUND: Hepatitis E virus (HEV) is an important cause of viral hepatitis. We evaluated the safety and efficacy of an HEV recombinant protein (rHEV) vaccine in a phase 2, randomized, double-blind, placebo-controlled trial. METHODS: In Nepal, we studied 2000 healthy adults susceptible to HEV infection who were randomly assigned to receive three doses of either the rHEV vaccine or placebo at months 0, 1, and 6. Active (including hospital) surveillance was used to identify acute hepatitis and adverse events. The primary end point was the development of hepatitis E after three vaccine doses. RESULTS: A total of 1794 subjects (898 in the vaccine group and 896 in the placebo group) received three vaccine doses; the total vaccinated cohort was followed for a median of 804 days. After three vaccine doses, hepatitis E developed in 69 subjects, of whom 66 were in the placebo group. The vaccine efficacy was 95.5% (95% confidence interval [CI], 85.6 to 98.6). In an intention-to-treat analysis that included all 87 subjects in whom hepatitis E developed after the first vaccine dose, 9 subjects were in the vaccine group, with a vaccine efficacy of 88.5% (95% CI, 77.1 to 94.2). Among subjects in a subgroup randomly selected for analysis of injection-site findings and general symptoms (reactogenicity subgroup) during the 8-day period after the administration of any dose, the proportion of subjects with adverse events was similar in the two study groups, except that injection-site pain was increased in the vaccine group (P=0.03). CONCLUSIONS: In a high-risk population, the rHEV vaccine was effective in the prevention of hepatitis E. (ClinicalTrials.gov number, NCT00287469 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lai, C. L., Ratziu, V., Yuen, M.-F., & Poynard, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15108-2 · Cited by 1,727
Emerson, S. U., & Purcell, R. H. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.384 · Cited by 785
Hepatitis B vaccine – do we need boosters?
Banatvala, J. E., & Van Damme, P. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00400.x · Cited by 207
Viremia, Fecal Shedding, and IgM and IgG Responses in Patients with Hepatitis E
Clayson, E. T., Myint, K. S. A., Snitbhan, R., Vaughn, D. W., Innis, B. L., Chan, L., Cheung, P., & Shrestha, M. P. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.4.927 · Cited by 188
Self-citationHepatitis viruses: changing patterns of human disease.
Purcell, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2401 · Cited by 147
Phylogenetic analysis of the caliciviruses
Berke, T., Golding, B., Jiang, X., Cubitt, D. W., Wolfaardt, M., Smith, A. W., & Matson, D. O. (1997) · Journal of Medical Virology · Cited by 110
Hepatitis E and its emergence in non-endemic areas.
Worm, H. C., Schlauder, G. G., & Brandstatter, G. (2002) · PubMed · Cited by 21
Cited by
Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
Kamar, N., Selves, J., Mansuy, J.-M., Ouezzani, L., Péron, J.-M., Guitard, J., Cointault, O., Esposito, L., Abravanel, F., Danjoux, M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706992 · Cited by 1,350
Zhu, F.-C., Zhang, J., Zhang, X.-F., Zhou, C., Wang, Z.-Z., Huang, S.-J., Wang, H., Yang, C.-L., Jiang, H.-M., Cai, J.-P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61030-6 · Cited by 803
Hepatitis E: An emerging awareness of an old disease
Purcell, R. H., & Emerson, S. U. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.008 · Cited by 700
Kamar, N., Dalton, H. R., Abravanel, F., & Izopet, J. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00057-13 · Cited by 675
Hepatitis E: an emerging infection in developed countries
Dalton, H. R., Bendall, R., Ijaz, S., & Banks, M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70255-x · Cited by 669
Hepatitis E Virus: Animal Reservoirs and Zoonotic Risk
Meng, X. J. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.03.017 · Cited by 491
Hoofnagle, J. H., Nelson, K. E., & Purcell, R. H. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204512 · Cited by 479
Long-Term Efficacy of a Hepatitis E Vaccine
Zhang, J., Zhang, X.-F., Huang, S.-J., Wu, T., Hu, Y.-M., Wang, Z.-Z., Wang, H., Jiang, H.-M., Wang, Y.-J., Yan, Q., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406011 · Cited by 378
Hepatitis-E-Virus: Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit
Gesundheit, M. D. A. B. D. B. F. (2015) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-014-2103-4 · Cited by 374
Johne, R., Plenge-Bonig, A., Hess, M., Ulrich, R. G., Reetz, J., & Schielke, A. (2010) · Journal of General Virology · doi:10.1099/vir.0.016584-0 · Cited by 362
Hepatitis E virus: advances and challenges
Nimgaonkar, I., Ding, Q., Schwartz, R. E., & Ploss, A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.150 · Cited by 352
Zoonotic hepatitis E: animal reservoirs and emerging risks
Pavio, N., Meng, X.-J., & Renou, C. (2010) · Veterinary Research · doi:10.1051/vetres/2010018 · Cited by 344
Pathogenesis and Treatment of Hepatitis E Virus Infection
Wedemeyer, H., Pischke, S., & Manns, M. P. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.014 · Cited by 336
Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury
Davern, T. J., Chalasani, N., Fontana, R. J., Hayashi, P. H., Protiva, P., Kleiner, D. E., Engle, R. E., Nguyen, H., Emerson, S. U., Purcell, R. H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.051 · Cited by 328
Meng, X.-J. (2011) · Virus Research · doi:10.1016/j.virusres.2011.01.016 · Cited by 283
Large-scale production and purification of VLP-based vaccines
Vicente, T., Roldão, A., Peixoto, C., Carrondo, M. J. T., & Alves, P. M. (2011) · Journal of Invertebrate Pathology · doi:10.1016/j.jip.2011.05.004 · Cited by 270
Drexler, J. F., Seelen, A., Corman, V. M., Fumie Tateno, A., Cottontail, V., Melim Zerbinati, R., Gloza-Rausch, F., Klose, S. M., Adu-Sarkodie, Y., Oppong, S. K., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00800-12 · Cited by 267
Guu, T. S. Y., Liu, Z., Ye, Q., Mata, D. A., Li, K., Yin, C., Zhang, J., & Tao, Y. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904848106 · Cited by 255
Nonhuman primate models of human viral infections
Estes, J. D., Wong, S. W., & Brenchley, J. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0005-7 · Cited by 255
Acute Liver Failure Including Acetaminophen Overdose
Fontana, R. J. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2008.03.005 · Cited by 249
Metadata
- Authors
- Shrestha, M. P., Scott, R. M., Joshi, D. M., Mammen, M. P., Thapa, G. B., Thapa, N., Myint, K. S. A., Fourneau, M., Kuschner, R. A., Shrestha, S. K., David, M. P., Seriwatana, J., Vaughn, D. W., Safary, A., Endy, T. P., & Innis, B. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-03
- Volume
- 356
- Issue
- 9
- Pages
- 895-903
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2023136941
- Cited by
- 551
- References
- 7
- FWCI
- 29.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.